Philadelphia, PA · Founded 2022 · Privately Held (backing)
Developer of curative medicines designed for neurological diseases. Latus Bio is based in Philadelphia, PA and was founded in 2022. It has raised $87.5 million.
Last price · $/share
—
Implied valuation
—
Total raised
$87.5M
Last round
—
Cap table — not yet on record
Latus Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Latus Bio with a free account
·The complete investor list: 12 names
·Watch Latus Bio: the Monday email on marks, rounds and moves
